• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1550400-23
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/07/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Evaluation summary: the device was received.Visual and functional inspections were performed on the returned device.The reported balloon rupture confirmed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling; therefore, no corrective action is required.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion located in the mid-proximal right anterior descending coronary artery that was 90% stenosed.When a 4.0 x 23 mm xience sierra stent deployment was attempted, the pressure of the indeflator would not increase.However, the stent was deployed at the intended site.While pressure escaped, inflation was performed again and again for successful deployment.Post-dilatation was performed with a non-compliant balloon to complete the procedure and an intravascular ultrasound was performed.When the stent delivery system was investigated outside the anatomy, a pinhole rupture was confirmed at the center part of the balloon.There was no reported adverse patient effect.There was no reported clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
(b)(4).Correction: remove conclusion code 4311.A visual, functional and scanning electronic microspy analysis were performed on the returned device.The reported balloon rupture was confirmed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no similar incidents from this lot.The reported event was concluded to be related to a potential quality issue.The issue is being addressed per internal operating procedures.Abbott vascular will continue to trend the performance of these devices.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8116563
Report Number2024168-2018-09141
Device Sequence Number1578298
Product Code NIQ
UDI-Device Identifier08717648227516
UDI-Public08717648227516
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 01/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/30/2021
Device Catalogue Number1550400-23
Device Lot Number8031241
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer11/19/2018
Initial Date Received by Manufacturer 11/07/2018
Supplement Date Received by Manufacturer01/22/2019
Initial Report FDA Received Date11/29/2018
Supplement Report FDA Received Date01/30/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-